GovChime
UEI: H2MLEFWV36N6 • CAGE: 62ES6

ABZYME THERAPEUTICS LLC (PA)

Registration and award facts

SAM.gov registration as of

Net obligations since FY2016
$1.85M
$1,849,456under this UEI
FY2026 obligations
$0
Provisional
Awards and orders
5
with positive net obligations
Latest action
Jun 17, 2020
SAM.gov registration
Active
Registration expiration date Jan 2, 2027

Registration

Entity structure
Partnership or Limited Liability Partnership
Business start date
Jun 22, 2010 (16 years)
Location
Pottstown, PA
State of incorporation
Pennsylvania

† FY2026 obligations (provisional; DoD awards signed after Jul 25, 2026 are not yet public).

Contract actions that the Department of Defense both funds and awards are withheld at the source for 90 days, so DoD awards signed after Jul 25, 2026 are not yet public.

Source: SAM.gov entity registration and FPDS contract actions recorded under UEI H2MLEFWV36N6. GovChime does not check exclusions.

Performance

Net obligations recorded under this UEI since FY2016. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.

Net obligations by fiscal year of action

  • FY2019: $799,814
  • FY2018: $799,998
  • FY2017: $49,906
  • FY2016: $199,738

Total across 4 fiscal years: $1,849,456

Top awarding agencies

Top awarding sub-agencies

Top NAICS by obligations

Top product and service codes by obligations

  • AJ52R&d- general science/technology: life sciences (applied research/exploratory development)$999,998, 54.1%
  • AN12R&d- medical: biomedical (applied research/exploratory development)$599,814, 32.4%
  • AJ11R&d- general science/technology: physical sciences (basic research)$249,644, 13.5%

Capabilities

SBA certifications

No certification in the SBA profile data.

Business types self-reported in SAM.gov registration:

  • Minority-Owned Business
  • Asian-Pacific American Owned

Federal Capability Statement

Provide services in recombinant antibody development, modification and production services

Capabilities & Services

Biotechnology Research
Therapeutic antibodies
Antibody development
Human antibodies
Camelid single domain antibodies
VHH
bispecific antibodies
blood brain barrier
Cancer
eye diseases
infectious diseases
diagnostic imaging
pre-targeted immunotherapy
in-cell antibody maturation.

Contracts

Latest awards and orders

  1. W911QY18C0004Definitive contractDepartment of DefenseDepartment of the ArmyLatest action
  2. 75N93019C00009Definitive contractDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  3. 75N91018C00031Definitive contractDepartment of Health and Human ServicesNational Institutes of HealthLatest action
  4. W911QY16P0229Purchase orderDepartment of DefenseDepartment of the ArmyLatest action
  5. W911QY16P0050Purchase orderDepartment of DefenseDepartment of the ArmyLatest action

Contact Info

As of . Source: SAM.gov Points of Contact.

SAM.gov registration for ABZYME THERAPEUTICS LLC lists a physical address and a separate mailing address, along with 4 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.

Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).

Physical Address

321 JONES BLVD

STE 300

POTTSTOWN, PA, 19464

USA

Mailing Address

321 JONES BLVD, STE 300

POTTSTOWN, PA, 19464

USA

Government Business Contact

HIEP T TRAN

CHIEF SCIENTIFIC OFFICER

321 JONES BOULEVARD

STE 300

POTTSTOWN, PA, 19464

USA

Electronic Business Contact

HIEP T TRAN

CHIEF SCIENTIFIC OFFICER

321 JONES BOULEVARD

STE 300

POTTSTOWN, PA, 19464

USA

Government Business Alternate Contact

HIEP T TRAN

CHIEF SCIENTIFIC OFFICER

321 JONES BOULEVARD

STE 300

POTTSTOWN, PA, 19464

USA

Electronic Business Alternate Contact

STEVE MANOBIANCO

COMMERCIAL DIRECTOR

321 JONES BOULEVARD

STE 300

POTTSTOWN, PA, 19464

USA

Additional Details

As of . Source: SAM.gov Entity Registration.

ABZYME THERAPEUTICS LLC has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires January 2, 2027.

Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.

Compliance & Risk Assessment

Source: SAM.gov FAR responses

Suspension/Debarment Status

SAM.gov registration reports no active exclusion

Public Display

Entity information is publicly displayed

Disaster Relief Registry

Not registered for disaster relief

Bonding Information

No bonding information provided

EDI

Not declared in SAM.gov

Business Structure

Source: SAM.gov
Profit Structure:For Profit Organization
Organization:Limited Liability Company

Registration Details

Source: SAM.gov

Initial Registration

Jul 5, 2010

Last Update

Jan 8, 2026

Registration Activation

Active — Jan 8, 2026

Fiscal Year End

1231

Country of Incorporation

USA

Congressional District

04